Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 51

Sort by

Sort Order Select

Journal Articles

Late Effects and Subsequent Neoplasms in Survivors of Adolescent and Young Adult Acute Lymphoblastic Leukemia: A Population-Based Analysis Including Impact of Front-Line Regimen Type

Lori S Muffly, MD, Fran Maguire, PhD MPH, Qian Li, MS, Vanessa Kennedy, MD, Theresa H.M. Keegan, PhD MS

Blood (2019) 134 (Supplement_1): 421.

https://doi.org/10.1182/blood-2019-124992

Published: 2019

Journal Articles

Carfilzomib Based Regimens for Treatment of Newly Diagnosed Multiple Myeloma: A Systematic Review

Maimoona Khan, MBBS, Asma Waheed, MBBS, Rida Ul Jannat, MBBS, Arafat Ali Ali Farooqui, MD, Muhammad Saad Farooqi, MD, Ali Younas Khan, MD, Madeeha Shafqat, Muhaddis Ejaz Ahmad, MD, Muhammad Abdullah Yousaf, MBBS, MD, Tariq Iqtidar Sadiq Syed, MD, Syed Maaz Abdullah, MBBS, Sravanthi Kotapati, MBBS, Irbaz Riaz, MDMMSc, Faiz Anwer, MD

Blood (2019) 134 (Supplement_1): 5588.

https://doi.org/10.1182/blood-2019-128833

Published: 2019

Journal Articles

Twice Weekly Induction with Ixazomib-Lenalidomide-Dexamethasone (IRd) Combination Followed By Extended IRD Consolidation and Lenalidomide Maintenance in Transplant Eligible Patients with Newly Diagnosed Multiple Myeloma (NDMM): A Phase 2 Study from the Intergroupe Francophone Du Myelome (IFM 2014-03)

Murielle Roussel, MD, Benjamin Hebraud, MD, Cyrille Hulin, MD, Xavier Leleu, MD PhD, Thierry Facon, MD, Eileen Boyle, MD PhD, Cyrille Touzeau, MD PhD, Brigitte Pegourie, MD, Aurore Perrot, MD PhD, Anne-Marie Stoppa, MD, Jean-Pierre Marolleau, MD PhD, Philippe Moreau, MD, Herve Avet-Loiseau, MD PhD, Laure Devlamynck, Valerie Lauwers-Cances, MD, Michel Attal, MD PhD

Blood (2019) 134 (Supplement_1): 3159.

https://doi.org/10.1182/blood-2019-123184

Published: 2019

Journal Articles

A Phase I Study of Nivolumab and Lenalidomide in Relapsed/ Refractory B Cell Lymphoma

David A. Bond, MD, Vedat Yildiz, Lai Wei, PhD, Lapo Alinari, MD PhD, Basem M. William, MRCP,MD, Jonathan E. Brammer, MD, Beth A. Christian, MD, Kristie A. Blum, MD, Kami J. Maddocks, MD

Blood (2019) 134 (Supplement_1): 4091.

https://doi.org/10.1182/blood-2019-130539

Published: 2019

Journal Articles

Hematological Changes in Chronic Sustained Hypoxia and Chronic Intermittent Hypoxia in a Mouse Model

Jihyun Song, PhD, Krishna M Sundar, MD, John Hoidal, MD, Josef T. Prchal, MD

Blood (2019) 134 (Supplement_1): 3525.

https://doi.org/10.1182/blood-2019-131309

Published: 2019

Journal Articles

Prevalence and Risk Factors for Opioid-Related Complications in Patients with Myeloproliferative Neoplasms: An International Survey of 502 Patients By the MPN Quality of Life Study Group

Holly L. Geyer, MD, Robyn M. Scherber, MD MPH, Gina Mazza, PhD, Blake Langlais, Leslie Padrnos, MD, Jeanne Palmer, MD, Amylou C. Dueck, PhD, Ruben A. Mesa, MD

Blood (2018) 132 (Supplement 1): 4297.

https://doi.org/10.1182/blood-2018-99-115143

Published: 2018

Journal Articles

Medical Conditions Among Survivors of Adolescent and Young Adult Non-Hodgkin Lymphoma (NHL), Acute Lymphoblastic Leukemia (ALL) and Acute Myeloid Leukemia (AML)

Theresa H.M. Keegan, PhD MS, Lori S Muffly, MD, Qian Li, MS, Elysia Alvarez, MD MPH, Ann M Brunson, MS, Marcio Malogolowkin, MD, Ted Wun, MD

Blood (2018) 132 (Supplement 1): 839.

https://doi.org/10.1182/blood-2018-99-111553

Published: 2018

Journal Articles

Burden of Hospital Readmissions for Venous Thromboembolism Among Patients with Cancer

Alpesh J. Amin, MD MBA, Steven Deitelzweig, MD, Jay Lin, PhD MBA, Melissa Lingohr-Smith, PhD, Brandy Menges, PhD, W. Richey Neuman, MD MPH

Blood (2018) 132 (Supplement 1): 365.

https://doi.org/10.1182/blood-2018-99-112288

Published: 2018

Journal Articles

Estimating the Burden of Hospital-Acquired Venous Thromboembolism: The Argument for Implementation of Mandatory Risk Reduction Strategies

Barry Kevane, MB, PhD, Mary Day, PhD, Noirin Bannon, Leo Lawler, MB, Tomas Breslin, MB, Claire Andrews, MB, Howard Johnson, PhD, Michael Fitzpatrick, Karen Murphy, MD, Olivia Mason, MSc, Sarah Kelliher, MB, Annemarie O'Neill, Fionnuala Donohue, Fionnuala Ni Ainle, MD PhD

Blood (2018) 132 (Supplement 1): 3515.

https://doi.org/10.1182/blood-2018-99-112143

Published: 2018

Journal Articles

Late Effects of CD19-Targeted CAR-T Cell Therapy

Ana Cordeiro, Evandro D Bezerra, Joshua Aiden Hill, MD, Cameron J. Turtle, MBBS, PhD, David G. Maloney, MD PhD, Merav Bar, MD

Blood (2018) 132 (Supplement 1): 223.

https://doi.org/10.1182/blood-2018-99-112023

Published: 2018

Journal Articles

In Children with Sickle Cell Anemia, Low Baseline BMI Is Associated with a Longitudinal Decline in FEV 1 % Predicted

Jodi-Anne T Stewart, BS, Mark Rodeghier, PhD, Michael R. DeBaun, MD MPH, Shaina M Willen, MD

Blood (2017) 130 (Supplement 1): 618.

https://doi.org/10.1182/blood.V130.Suppl_1.618.618

Published: 2017

Journal Articles

Did Patients with Renal Disease Receive Sufficient Prophylaxis for Venous Thromboembolism in the Real-World Settings?: A Study Among Hospitalized Acutely Medically Ill Patients

Alpesh J. Amin, MD, Richey Neuman, MD MPH, Melissa Lingohr-Smith, PhD, Brandy Menges, PhD, Jay Lin, PhD MBA

Blood (2017) 130 (Supplement 1): 3416.

https://doi.org/10.1182/blood.V130.Suppl_1.3416.3416

Published: 2017

Journal Articles

Phase 2 Study of Carfilzomib, Thalidomide, and Low-Dose Dexamethasone As Induction/Consolidation in Newly Diagnosed, Transplant Eligible Patients with Multiple Myeloma, the Carthadex Trial

Ruth Wester, Bronno van der Holt, PhD, Emelie Asselbergs, Mark van Duin, PhD, Sonja Zweegman, MD PhD, Marie Jose Kersten, MD PhD, Edo Vellenga, MDPhD, Marinus van Marwijk Kooy, MD, Okke de Weerdt, MD, Monique Minnema, Sarah Lonergan, MSc, Antonio Palumbo, MD, Henk M. Lokhorst, MD PhD, Annemiek Broijl, MD PhD, Pieter Sonneveld, MD PhD

Blood (2016) 128 (22): 1141.

https://doi.org/10.1182/blood.V128.22.1141.1141

Published: 2016

Journal Articles

Adenosine A2B Receptor Promotes Erythrocyte Oxygen Release to Counteract Tissue Hypoxia and Injury

Zhangzhe Peng, MD, Renna Luo, MD, Anren Song, PhD, Kaiqi Sun, BS, Hong Liu, MD, Yujin Zhang, PhD, Morayo G. Adebiyi, BS, Yang Xia, MD PhD, Rodney E. Kellems, PhD, Aji Huang, BS, MS

Blood (2016) 128 (22): 2424.

https://doi.org/10.1182/blood.V128.22.2424.2424

Published: 2016

Journal Articles

Lenalidomide Maintenance after Front Line Therapy Substantially Prolongs Progression Free Survival in High Risk CLL: Interim Results of a Phase 3 Study (CLL M1 study of the German CLL Study Group)

Blood (2016) 128 (22): 229.

https://doi.org/10.1182/blood.V128.22.229.229

Published: 2016

Journal Articles

Sociodemographic Factors Predict Medical Conditions Among Five-Year Survivors of Adolescent and Young Adult Hodgkin Lymphoma

Theresa Keegan, Qian Li, Amy Steele, Elysia Alvarez, MD MPH, Ann M Brunson, MS, Christopher Flowers, MDMS, Sally L. Glaser, PhD, Ted Wun, MD

Blood (2016) 128 (22): 693.

https://doi.org/10.1182/blood.V128.22.693.693

Published: 2016

Journal Articles

A Prospective, Multicenter, Randomized Study of Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Investigator's Choice in the Treatment of Patients with Relapsed/Refractory Adult T-Cell Leukemia-Lymphoma: Overall Response Rate, Progression-Free Survival, and Overall Survival

Blood (2016) 128 (22): 4159.

https://doi.org/10.1182/blood.V128.22.4159.4159

Published: 2016

Journal Articles

Evaluating the Efficacy and Toxicity of Two Lenalidomide Dose Regimens for the Treatment of Older Relapsed Multiple Myeloma Patients with Co-Morbidities: A Multi-Site Study at the Veteran's Administration Hospitals

Sarvari V Yellapragada, MD, Shayna Sarosiek, MD, Neelima D Prabhala, B.A., Mehmet Kemalsamur, PhD, Antoun Houranieh, RPh., M.S., PhD, Saulius Girnius, MD, Praveen Tumula, MD, Suman Kambhampati, MD, Nirmala Bhoopalam, MD, Rao H Prabhala, PhD, David Roodman, MD, PhD, Alan Lichtenstein, MD, Nikhil C Munshi, MD

Blood (2015) 126 (23): 5370.

https://doi.org/10.1182/blood.V126.23.5370.5370

Published: 2015

Journal Articles

Ambulatory Management of Anemia: A Retrospective View from an Italian Multidisciplinary Team

Eleonora Arboscello, MD, Elisa Molinari, MD, Francesco Tolomeo, MD, Lisette Del Corso, MD, Luana Vignolo, MD, Gianluca Ubezio, MD, Paolo Carlier, MD, Paolo Strada, MD, Riccardo Ghio, PhD, Francesco Puppo, PhD, Paola Mangini, MD, Sabrina Beltramini, MD, Pietro Dulbecco, MD, Paola Anserini, MD, Maria Teresa van Lint, MD, Andrea Bacigalupo, MD, Fabio Guolo, MD, Marino Clavio, MD, Andrea Bellodi, MD

Blood (2015) 126 (23): 5583.

https://doi.org/10.1182/blood.V126.23.5583.5583

Published: 2015

Journal Articles

Clinical disease due to enterovirus D68 in adult hematologic malignancy patients and hematopoietic cell transplant recipients

Alpana Waghmare, Steven A. Pergam, Keith R. Jerome, Janet A. Englund, Michael Boeckh, Jane Kuypers

Blood (2015) 125 (11): 1724–1729.

https://doi.org/10.1182/blood-2014-12-616516

Published: 2015

NARROW

Late Effects and Subsequent Neoplasms in Survivors of Adolescent and Young Adult Acute Lymphoblastic Leukemia: A Population-Based Analysis Including Impact of Front-Line Regimen Type

Carfilzomib Based Regimens for Treatment of Newly Diagnosed Multiple Myeloma: A Systematic Review

A Phase I Study of Nivolumab and Lenalidomide in Relapsed/ Refractory B Cell Lymphoma

Hematological Changes in Chronic Sustained Hypoxia and Chronic Intermittent Hypoxia in a Mouse Model

Prevalence and Risk Factors for Opioid-Related Complications in Patients with Myeloproliferative Neoplasms: An International Survey of 502 Patients By the MPN Quality of Life Study Group

Medical Conditions Among Survivors of Adolescent and Young Adult Non-Hodgkin Lymphoma (NHL), Acute Lymphoblastic Leukemia (ALL) and Acute Myeloid Leukemia (AML)

Burden of Hospital Readmissions for Venous Thromboembolism Among Patients with Cancer

Estimating the Burden of Hospital-Acquired Venous Thromboembolism: The Argument for Implementation of Mandatory Risk Reduction Strategies

Late Effects of CD19-Targeted CAR-T Cell Therapy

In Children with Sickle Cell Anemia, Low Baseline BMI Is Associated with a Longitudinal Decline in FEV 1 % Predicted

Did Patients with Renal Disease Receive Sufficient Prophylaxis for Venous Thromboembolism in the Real-World Settings?: A Study Among Hospitalized Acutely Medically Ill Patients

Phase 2 Study of Carfilzomib, Thalidomide, and Low-Dose Dexamethasone As Induction/Consolidation in Newly Diagnosed, Transplant Eligible Patients with Multiple Myeloma, the Carthadex Trial

Adenosine A2B Receptor Promotes Erythrocyte Oxygen Release to Counteract Tissue Hypoxia and Injury

Lenalidomide Maintenance after Front Line Therapy Substantially Prolongs Progression Free Survival in High Risk CLL: Interim Results of a Phase 3 Study (CLL M1 study of the German CLL Study Group)

Sociodemographic Factors Predict Medical Conditions Among Five-Year Survivors of Adolescent and Young Adult Hodgkin Lymphoma

A Prospective, Multicenter, Randomized Study of Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Investigator's Choice in the Treatment of Patients with Relapsed/Refractory Adult T-Cell Leukemia-Lymphoma: Overall Response Rate, Progression-Free Survival, and Overall Survival

Evaluating the Efficacy and Toxicity of Two Lenalidomide Dose Regimens for the Treatment of Older Relapsed Multiple Myeloma Patients with Co-Morbidities: A Multi-Site Study at the Veteran's Administration Hospitals

Ambulatory Management of Anemia: A Retrospective View from an Italian Multidisciplinary Team

Clinical disease due to enterovirus D68 in adult hematologic malignancy patients and hematopoietic cell transplant recipients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only